Peter D. Smith is a Director of New Modalities Chemistry in AstraZeneca's Early Chemical Development Group. They previously held positions at Zeneca Agrochemicals as a Synthetic Chemist and served as a Postdoctoral Research Associate at the University of Sussex. From 2002 to 2012, they were a Senior Research Scientist at AstraZeneca, focusing on the planning and delivery of non-GMP active pharmaceutical ingredients. Peter earned a PhD in the synthesis of pipecolic acid derivatives from Heriot-Watt University and holds a 1st Class BSc in Chemistry from The University of Glasgow.
This person is not in the org chart
This person is not in any teams
This person is not in any offices